Molecular pathology of lung cancer: key to personalized medicine-Reference-Cited by-同舟云学术

Molecular pathology of lung cancer: key to personalized medicine

Published:2012-01-27 Issue:3 Volume:25 Page:347-369
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Cheng Liang,Alexander Riley E,MacLennan Gregory T,Cummings Oscar W,Montironi Rodolfo,Lopez-Beltran Antonio,Cramer Harvey M,Davidson Darrell D,Zhang Shaobo

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2011215.pdf

Reference244 articles.

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.

2. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212–236.

3. Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer: clinical practice guidelines in oncology. J Natl Compr Canc Netw 2011;8:740–801.

4. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244–285.

5. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497–1500.

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro evidence for the potential of EGFR inhibitors to decrease the TGF-β1-induced dispersal of circulating tumour cell clusters mediated by EGFR overexpression;Scientific Reports;2024-08-28

2. Clinicopathological significance of mutation profile detected by next generation sequencing in different metastatic organs of non-small cell lung cancers;Pathology - Research and Practice;2024-08

3. EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue;Chemical Biology & Drug Design;2024-04

4. Advances in 3D bioprinting for regenerative medicine applications;Regenerative Biomaterials;2024-01-01

5. Pulmonary Disease;Geriatric Medicine;2024